Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multicentre trials: a US regulatory perspective.

Charles Anello1, Robert T O'Neill, Satya Dubey

  • 1Office of Biostatistics, Center for Drug Evaluation and Research, Food and Drug Administration, USA. charles.anello@fda.hhs.gov

Statistical Methods in Medical Research
|June 23, 2005
PubMed
Summary

Multicentre trials are crucial for drug development, increasingly involving multinational and multiregional studies. This paper offers a framework for their regulatory use in the US, examining key guidelines and data analysis challenges.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>Siphoviridae</i> phage tails co-enrich with ex vivo amyloids.

bioRxiv : the preprint server for biology·2026
Same author

Helical reconstruction of amyloids in cryoSPARC.

Acta crystallographica. Section F, Structural biology communications·2026
Same author

Three-Dimensional Visualization and Proteomic Analysis of Human Cardiac Transthyretin Amyloidosis Tissue Reveals Microangiopathy and Capillary Occlusion.

Journal of the American Heart Association·2026
Same author

3D Visualization and Proteomic Analysis of Human Cardiac Transthyretin Amyloidosis Tissue Reveals Microangiopathy and Capillary Occlusion.

bioRxiv : the preprint server for biology·2026
Same author

Cathepsin C-Catalyzed Ligation Generates Intralysosomal Amyloid Fibrils from Dipeptide Esters.

bioRxiv : the preprint server for biology·2026
Same author

Mechanochemical Approaches to Fundamental Studies in Soft-Matter Physics.

Angewandte Chemie (International ed. in English)·2024

Area of Science:

  • Drug Development
  • Clinical Trials
  • Regulatory Science

Background:

  • Multicentre trials are fundamental in pharmaceutical research and development.
  • These trials are increasingly adopting multinational and multiregional designs.
  • Understanding regulatory frameworks is essential for effective multicentre trial implementation.

Observation:

  • The United States regulatory perspective on multicentre trials is examined.
  • Key historical milestones and standards related to multicentre trials are reviewed.
  • Comparative analysis of approaches in major regulatory documents is presented.

Findings:

  • Similarities and differences in multicentre trial guidelines from regulatory bodies are identified.
  • Specific attention is paid to the Guideline for New Drug Applications, ICH guidelines, and FDA guidance.

Related Experiment Videos

  • Consideration is given to the complexities of analyzing data from multicentre trials.

    • Implications:

    • Provides a conceptual framework for leveraging multicentre trials in drug development.
    • Highlights the importance of harmonized standards in multinational clinical research.
    • Informs regulatory strategy and data analysis for global drug approval processes.